Protalix BioTherapeutics Inc (PLX)
1.75
-0.01
(-0.57%)
USD |
NYAM |
Dec 23, 16:00
1.75
0.00 (0.00%)
After-Hours: 18:20
Protalix BioTherapeutics Free Cash Flow: 7.171M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Accuray Inc | -14.24M |
| AIM ImmunoTech Inc | -21.33M |
| Perspective Therapeutics Inc | -40.58M |
| Electromed Inc | 11.30M |
| Armata Pharmaceuticals Inc | -42.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.105M |
| Cash from Investing (Quarterly) | 20.33M |
| Cash from Financing (Quarterly) | -20.42M |
| Free Cash Flow Per Share (Quarterly) | 0.0495 |
| Free Cash Flow to Equity (Quarterly) | 24.44M |
| Free Cash Flow to Firm (Quarterly) | 4.143M |
| Free Cash Flow Yield | 5.22% |